rabbit monoclonal anti braf (Cell Signaling Technology Inc)

Cell Signaling Technology Inc is a verified supplier

Cell Signaling Technology Inc manufactures this product

About

News

Press Release

Team

Advisors

Partners

Contact

Bioz Stars

Bioz vStars

Buy from Supplier

Structured Review

Cell Signaling Technology Inc rabbit monoclonal anti braf
Rabbit Monoclonal Anti Braf, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 94/100, based on 78 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rabbit+monoclonal+anti+braf/B-Raf+Rabbit+mAb/pmc12992859-49-26-29
Average 94 stars, based on 78 article reviews

rabbit monoclonal anti braf - by Bioz Stars, 2026-10

94/100 stars

Images

other:

Article Title: In vivo vulnerabilities to GPX4 and HDAC inhibitors in drug-persistent versus drug-resistant BRAF V600E lung adenocarcinoma
Article Snippet: Rabbit monoclonal anti-BRAF (clone 55C6) , Cell signaling Technology , Cat#9433; RRID: AB_2259354.

Article Title: GDC-0879, a BRAF V600E inhibitor, protects kidney podocytes from death
Article Snippet: Rabbit monoclonal anti-BRAF , Cell Signaling Technology , Cat#14814, RRID: N/A.

Nucleic Acid Electrophoresis:

Article Title: Distinct clinical and genomic profiles of braf mutation subtypes in Chinese colorectal cancer: a retrospective cohort study with cross-population validation
Article Snippet: Protein concentration was quantified using the BCA Protein Assay Kit (Vazyme). .. Equal amounts of protein were resolved by SDS-polyacrylamide gel electrophoresis, transferred onto polyvinylidene difluoride (PVDF) membranes (Vazyme), and probed overnight at 4 °C with primary antibodies: Rabbit monoclonal anti-BRAF (Cell Signaling Technology, #9433S) and Recombinant Rabbit anti-BRAFV600E (Thermo Fisher Scientific, #MA5-24661), GAPDH (Proteintech, GAPDH Monoclonal antibody, #60004-1-Ig). .. Signal detection was performed using horseradish peroxidase-conjugated secondary antibodies (Jackson ImmunoResearch), and chemiluminescent images were acquired with an Amersham Imager 600 (Cytiva).

Article Title: Distinct clinical and genomic profiles of braf mutation subtypes in Chinese colorectal cancer: a retrospective cohort study with cross-population validation.
Article Snippet: Protein concentration was quantified using the BCA Protein Assay Kit (Vazyme). .. Equal amounts of protein were resolved by SDS-polyacrylamide gel electrophoresis, transferred onto polyvinylidene difluoride (PVDF) membranes (Vazyme), and probed overnight at 4 °C with primary antibodies: Rabbit monoclonal anti-BRAF (Cell Signaling Technology, #9433S) and Recombinant Rabbit antiBRAFV600E (Thermo Fisher Scientific, #MA5-24661), GAPDH (Proteintech, GAPDH Monoclonal antibody, #60004-1-Ig). .. Signal detection was performed using horseradish peroxidase-conjugated secondary antibodies (Jackson ImmunoResearch), and chemiluminescent images were acquired with an Amersham Imager 600 (Cytiva).

Recombinant:

Article Title: Distinct clinical and genomic profiles of braf mutation subtypes in Chinese colorectal cancer: a retrospective cohort study with cross-population validation.
Article Snippet: Protein concentration was quantified using the BCA Protein Assay Kit (Vazyme). .. Equal amounts of protein were resolved by SDS-polyacrylamide gel electrophoresis, transferred onto polyvinylidene difluoride (PVDF) membranes (Vazyme), and probed overnight at 4 °C with primary antibodies: Rabbit monoclonal anti-BRAF (Cell Signaling Technology, #9433S) and Recombinant Rabbit antiBRAFV600E (Thermo Fisher Scientific, #MA5-24661), GAPDH (Proteintech, GAPDH Monoclonal antibody, #60004-1-Ig). .. Signal detection was performed using horseradish peroxidase-conjugated secondary antibodies (Jackson ImmunoResearch), and chemiluminescent images were acquired with an Amersham Imager 600 (Cytiva).

Immunodetection:

Article Title: A new water soluble MAPK activator exerts antitumor activity in melanoma cells resistant to the BRAF inhibitor vemurafenib.
Article Snippet: Accepted Manuscript Title: A new water soluble MAPK activator exerts antitumor activity in melanoma cells resistant to the BRAF inhibitor vemurafenib Author: Grazia Graziani Simona Artuso Anastasia De Luca Alessia Muzi Dante Rotili Manuel Scimeca Maria Grazia Atzori Claudia Ceci Antonello Mai Carlo Leonetti Lauretta Levati Elena Bonanno Lucio Tentori Anna Maria Caccuri PII: S0006-2952(15)00149-5 DOI: http://dx.doi.org/doi:10.1016/j.bcp.2015.03.004 Reference: BCP 12203 To appear in: BCP Received date: 16-2-2015 Accepted date: 10-3-2015 Please cite this article as: Graziani G, Artuso S, De Luca A, Muzi A, Rotili D, Scimeca M, Atzori MG, Ceci C, Mai A, Leonetti C, Levati L, Bonanno E, Tentori L, Caccuri AM, A new water soluble MAPK activator exerts antitumor activity in melanoma cells resistant to the BRAF inhibitor vemurafenib, Biochemical Pharmacology (2015), http://dx.doi.org/10.1016/j.bcp.2015.03.004 This is a PDF file of an unedited manuscript that has been accepted for publication.. As a service to our customers we are providing this early version of the manuscript.. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final form.

Review